Investment Analysts’ updated eps estimates for Tuesday, March 4th:
Albertsons Companies (NYSE:ACI) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $26.00 price target on the stock.
ADMA Biologics (NASDAQ:ADMA) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $25.00 target price on the stock.
AnaptysBio (NASDAQ:ANAB) had its neutral rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $22.00 price target on the stock.
Annexon (NASDAQ:ANNX) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $16.00 target price on the stock.
Artelo Biosciences (NASDAQ:ARTL) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $5.00 price target on the stock.
AST SpaceMobile (NASDAQ:ASTS) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $30.00 price target on the stock.
Avadel Pharmaceuticals (NASDAQ:AVDL) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $21.00 price target on the stock.
AvePoint (NASDAQ:AVPT) had its outperform rating reiterated by analysts at William Blair.
Biodesix (NASDAQ:BDSX) had its outperform rating reaffirmed by analysts at William Blair.
Biohaven (NYSE:BHVN) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $61.00 target price on the stock.
Biohaven (NYSE:BHVN) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $54.00 price target on the stock.
BRC (NYSE:BRCC) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $6.00 target price on the stock.
CalciMedica (NASDAQ:CALC) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $16.00 target price on the stock.
Canaan (NASDAQ:CAN) had its buy rating reissued by analysts at Rosenblatt Securities. They currently have a $8.00 price target on the stock.
Canaan (NASDAQ:CAN) had its buy rating reissued by analysts at HC Wainwright. They currently have a $3.00 price target on the stock.
Capricor Therapeutics (NASDAQ:CAPR) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $77.00 target price on the stock.
Cameco (NYSE:CCJ) (TSE:CCO) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $90.00 target price on the stock.
COMPASS Pathways (NASDAQ:CMPS) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $45.00 target price on the stock.
Datadog (NASDAQ:DDOG) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $160.00 price target on the stock.
Viant Technology (NASDAQ:DSP) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $21.00 price target on the stock.
Emergent BioSolutions (NYSE:EBS) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $15.00 price target on the stock.
Ekso Bionics (NASDAQ:EKSO) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $9.00 price target on the stock.
Esperion Therapeutics (NASDAQ:ESPR) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $16.00 price target on the stock.
European Wax Center (NASDAQ:EWCZ) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. They currently have a $6.00 price target on the stock.
Edgewise Therapeutics (NASDAQ:EWTX) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $56.00 target price on the stock.
Chesapeake Energy (NASDAQ:EXE) had its equal weight rating reaffirmed by analysts at Stephens. Stephens currently has a $86.00 price target on the stock.
Shift4 Payments (NYSE:FOUR) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $154.00 price target on the stock.
Fortrea (NASDAQ:FTRE) had its market perform rating reissued by analysts at William Blair.
Genius Sports (NYSE:GENI) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $12.00 target price on the stock.
Grove Collaborative (NYSE:GROV) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $2.00 target price on the stock.
GitLab (NASDAQ:GTLB) had its outperform rating reissued by analysts at Macquarie. The firm currently has a $90.00 price target on the stock.
GitLab (NASDAQ:GTLB) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $80.00 price target on the stock.
GitLab (NASDAQ:GTLB) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $80.00 price target on the stock.
GitLab (NASDAQ:GTLB) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $85.00 target price on the stock.
Hoth Therapeutics (NASDAQ:HOTH) had its buy rating reiterated by analysts at D. Boral Capital. D. Boral Capital currently has a $5.00 target price on the stock.
Hut 8 (NASDAQ:HUT) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $30.00 target price on the stock.
Hut 8 (NASDAQ:HUT) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a $32.00 target price on the stock.
Jamf (NASDAQ:JAMF) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $25.00 target price on the stock.
Microchip Technology (NASDAQ:MCHP) had its buy rating reissued by analysts at Rosenblatt Securities. They currently have a $70.00 price target on the stock.
MongoDB (NASDAQ:MDB) had its buy rating reaffirmed by analysts at Rosenblatt Securities. They currently have a $350.00 price target on the stock.
Montrose Environmental Group (NYSE:MEG) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $39.00 price target on the stock.
Morgan Stanley Direct Lending (NYSE:MSDL) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $22.00 price target on the stock.
N-able (NYSE:NABL) had its market perform rating reiterated by analysts at BMO Capital Markets. They currently have a $8.50 price target on the stock, down from their previous price target of $13.50.
Nebius Group (NASDAQ:NBIS) had its buy rating reaffirmed by analysts at BWS Financial. They currently have a $60.00 price target on the stock.
Neumora Therapeutics (NASDAQ:NMRA) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $5.00 price target on the stock.
Neumora Therapeutics (NASDAQ:NMRA) had its sector perform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $4.00 target price on the stock.
Ocular Therapeutix (NASDAQ:OCUL) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $15.00 target price on the stock.
Okta (NASDAQ:OKTA) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $115.00 price target on the stock.
Olaplex (NASDAQ:OLPX) had its market perform rating reissued by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $2.00 target price on the stock.
ON (NYSE:ONON) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $64.00 price target on the stock.
ON (NYSE:ONON) had its outperform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $67.00 target price on the stock.
Pliant Therapeutics (NASDAQ:PLRX) had its neutral rating reaffirmed by analysts at HC Wainwright.
Pliant Therapeutics (NASDAQ:PLRX) had its neutral rating reissued by analysts at Cantor Fitzgerald.
Pliant Therapeutics (NASDAQ:PLRX) had its hold rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $10.00 target price on the stock.
uniQure (NASDAQ:QURE) had its buy rating reissued by analysts at HC Wainwright. They currently have a $70.00 target price on the stock.
Ready Capital (NYSE:RC) had its neutral rating reissued by analysts at Wedbush. They currently have a $6.00 target price on the stock, down from their previous target price of $8.00.
Repay (NASDAQ:RPAY) had its overweight rating reiterated by analysts at Stephens. The firm currently has a $11.00 target price on the stock.
Cassava Sciences (NASDAQ:SAVA) had its neutral rating reissued by analysts at HC Wainwright.
Stitch Fix (NASDAQ:SFIX) had its market perform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $6.00 target price on the stock.
Syndax Pharmaceuticals (NASDAQ:SNDX) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $51.00 price target on the stock.
Stoneridge (NYSE:SRI) had its outperform rating reiterated by analysts at Barrington Research. They currently have a $16.00 price target on the stock.
ThredUp (NASDAQ:TDUP) had its hold rating reissued by analysts at Needham & Company LLC.
ThredUp (NASDAQ:TDUP) had its outperform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $3.00 target price on the stock.
TG Therapeutics (NASDAQ:TGTX) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $55.00 price target on the stock.
VolitionRx (NYSE:VNRX) had its buy rating reaffirmed by analysts at D. Boral Capital. D. Boral Capital currently has a $5.00 target price on the stock.
Wendy’s (NASDAQ:WEN) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $17.00 target price on the stock.
Receive News & Ratings for Albertsons Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albertsons Companies Inc and related companies with MarketBeat.com's FREE daily email newsletter.
